These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12691632)

  • 1. Where do we go from here? Relations between the medical profession and the pharmaceutical industry.
    Alpert JS
    Curr Cardiol Rep; 2003 May; 5(3):169-70. PubMed ID: 12691632
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine and the pharmaceutical industry: a call to action.
    Stiles MM; Barrett B
    Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
    [No Abstract]   [Full Text] [Related]  

  • 3. Physician-industry relations--will fewer gifts make a difference?
    Steinbrook R
    N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
    [No Abstract]   [Full Text] [Related]  

  • 4. A national survey of physician-industry relationships.
    Sade RM
    N Engl J Med; 2007 Aug; 357(5):507; author reply 508. PubMed ID: 17671263
    [No Abstract]   [Full Text] [Related]  

  • 5. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
    Morin K; Morse LJ
    Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
    [No Abstract]   [Full Text] [Related]  

  • 6. When physician-industry interactions go awry.
    Kassirer JP
    J Pediatr; 2006 Jul; 149(1 Suppl):S43-6. PubMed ID: 16829243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethics for the pediatrician: physician interaction with the pharmaceutical industry.
    Cicero MX; Curi MB; Mercurio M
    Pediatr Rev; 2011 Jan; 32(1):e1-3. PubMed ID: 21196498
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug representatives: giving you lunch or stealing your soul?
    Higgins SP
    Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in managing physician-industry relationships.
    Rothman DJ; Chimonas S
    JAMA; 2008 Sep; 300(9):1067-9. PubMed ID: 18768417
    [No Abstract]   [Full Text] [Related]  

  • 10. The baby with the bathwater.
    Buyske J
    Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
    [No Abstract]   [Full Text] [Related]  

  • 11. A policy of no pharmaceutical industry sponsorship: a case for health equity.
    Pinhao Chao P
    N Z Med J; 2011 Oct; 124(1344):115-6. PubMed ID: 22016176
    [No Abstract]   [Full Text] [Related]  

  • 12. Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention?
    Grande D
    J Gen Intern Med; 2010 Jan; 25(1):79-83. PubMed ID: 19756874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Zealand doctors and the pharmaceutical industry--time to cut the cord?
    Menkes DB
    N Z Med J; 2011 Aug; 124(1341):6-8. PubMed ID: 21959629
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmaceutical industry has a contribution to make to evidence-based healthcare.
    Sheehy K
    N Z Med J; 2012 Jan; 125(1348):110-1. PubMed ID: 22282289
    [No Abstract]   [Full Text] [Related]  

  • 15. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

  • 16. Banning pharmaceutical sponsorship: is ethical apartheid the right road ahead?
    Gravatt L
    N Z Med J; 2011 Nov; 124(1345):96-7. PubMed ID: 22072176
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions between emergency medicine programs and the pharmaceutical industry.
    Keim SM; Mays MZ; Grant D
    Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industry relations with emergency medicine graduate medical education programs.
    Kowalenko T; Char D; Marco C; Asher S; Raja A; Farrell S; Sokolove PE;
    Acad Emerg Med; 2009 Oct; 16(10):1025-30. PubMed ID: 19799581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug makers pay for lunch as they pitch.
    Saul S
    N Y Times Web; 2006 Jul; ():A1, C7. PubMed ID: 16909492
    [No Abstract]   [Full Text] [Related]  

  • 20. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
    Rodwin MA
    J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.